Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Esperion Therapeutics, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit – ESPR

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news